Anti-PD-1 cancer star nivolumab wins world’s first regulatory approval
10/07/2014
The anti-PD-1 immuno-oncology drug star nivolumab has won the race to the world’s first regulatory checkered flag for approval. Ono Pharmaceutical, which picked up the